News

By I. Edwards HealthDay ReporterWEDNESDAY, May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall.The new framework, announced Tuesday, says adults 65 and older, and people with certain …

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy

No significantly increased risk seen with exposure to different triptan intensities and duration, alone or in combination with other preventive medications

Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation

Risk discrimination of incident myocardial infarction events improved by adding coronary artery calcium to PREDICT risk

Risk of death remained similar following simple hysterectomy versus other types of hysterectomy in adjusted analyses

Presence of tumor-related epilepsy not a significant predictor of survival in multivariate analyses

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy

The steepest decrease in FEV1 seen for those with persistently positive mucus plugs who resume smoking

Explore the potential link between diabetes and cancer, examining shared risk factors and biological mechanisms in this comprehensive analysis.